147 related articles for article (PubMed ID: 35385938)
1. [Clinical characteristics and risk factors of pericardial effusion after hematopoietic stem cell transplantation in children with thalassemia major].
Yang CL; Wang XD; Zhou XH; Wang CJ; Zhang XL; Li Y; Yu Y; Liu SX
Zhonghua Er Ke Za Zhi; 2022 Apr; 60(4):323-328. PubMed ID: 35385938
[No Abstract] [Full Text] [Related]
2. Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation.
Kubo H; Imataki O; Fukumoto T; Oku M; Ishida T; Kubo YH; Kida JI; Uemura M; Fujita H; Ohno H; Ide M; Ohnishi H; Kadowaki N
Transplant Cell Ther; 2021 Nov; 27(11):949.e1-949.e8. PubMed ID: 34333179
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study of risk factors for pericardial effusion after haematopoietic stem cell transplantation in children.
Tong K; Meng Y; Zhang L; Lei X; Guan X; Xiao L; Yu J; Dou Y
Hematology; 2023 Dec; 28(1):2245259. PubMed ID: 37551721
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors for hemorrhagic cystitis in children with β-thalassemia major after allogeneic hematopoietic stem cell transplantation].
Chen XL; Luo XJ; Cao K; Huang T; Luo YG; Yang CL; Chen YS
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Oct; 25(10):1046-1051. PubMed ID: 37905762
[TBL] [Abstract][Full Text] [Related]
5. Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation.
Yanagisawa R; Ishii E; Motoki N; Yamazaki S; Morita D; Sakashita K; Shiohara M; Tanaka M; Hidaka Y; Kubota N; Hidaka E; Ogiso Y; Nakamura T; Yasukochi S
Transpl Int; 2015 May; 28(5):565-74. PubMed ID: 25644234
[TBL] [Abstract][Full Text] [Related]
6. Increased Body Mass Index Augments Endothelial Injury and Clinical Outcomes after Hematopoietic Stem Cell Transplantation.
Koo J; Ziady AG; Reynaud D; Abdullah S; Luebbering N; Kahn S; Langenberg L; Strecker L; Lake K; Dandoy CE; Lane A; Myers KC; Sabulski A; Good S; Nalapareddy K; Solomon M; Siefert ME; Skala E; Jodele S; Davies SM
Transplant Cell Ther; 2023 Nov; 29(11):704.e1-704.e8. PubMed ID: 37625594
[TBL] [Abstract][Full Text] [Related]
7. Factors Affecting Survival in Children With Pericardial Effusion After Hematopoietic Stem Cell Transplantation.
Jaing TH; Chen SH; Wen YC; Chang TY; Tsai DY; Chung HT; Tsay PK
Cell Transplant; 2017 Nov; 26(11):1792-1797. PubMed ID: 29338379
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis.
Luo L; Xiong H; Chen Z; Yang L; Sun M; Lu W; Tao F; Wang Z; Li J; Li Z; Tang S
Clin Transl Oncol; 2023 Aug; 25(8):2451-2461. PubMed ID: 36973479
[TBL] [Abstract][Full Text] [Related]
9. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review of Signs and Symptoms Associated with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy.
Dandoy CE; Tsong WH; Sarikonda K; McGarvey N; Perales MA
Transplant Cell Ther; 2023 Apr; 29(4):282.e1-282.e9. PubMed ID: 36592719
[TBL] [Abstract][Full Text] [Related]
11. Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.
Dandoy CE; Davies SM; Hirsch R; Chima RS; Paff Z; Cash M; Ryan TD; Lane A; El-Bietar J; Myers KC; Jodele S
Biol Blood Marrow Transplant; 2015 Jan; 21(1):113-8. PubMed ID: 25300868
[TBL] [Abstract][Full Text] [Related]
12. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
[TBL] [Abstract][Full Text] [Related]
13. Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy.
Okamura H; Nakamae H; Shindo T; Ohtani K; Hidaka Y; Ohtsuka Y; Makuuchi Y; Kuno M; Takakuwa T; Harada N; Nishimoto M; Nakashima Y; Koh H; Hirose A; Nakamae M; Wakamiya N; Hino M; Inoue N
Front Immunol; 2021; 12():695037. PubMed ID: 34326846
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Outcome of Pericardial Effusion in Pediatric Patients After Hematopoietic Stem Cell Transplant: A Single-institution Experience.
Diamond M; Ruiz-Mesa C; Corrales-Medina FF; Tamariz LJ; Ziga E; Swaminathan S
J Pediatr Hematol Oncol; 2018 Mar; 40(2):132-136. PubMed ID: 28945662
[TBL] [Abstract][Full Text] [Related]
15. Early and late complications following hematopoietic stem cell transplantation in pediatric patients - A retrospective analysis over 11 years.
Hierlmeier S; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
PLoS One; 2018; 13(10):e0204914. PubMed ID: 30325953
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Tzeng CH
Br J Haematol; 2015 Jun; 169(5):737-45. PubMed ID: 25818840
[TBL] [Abstract][Full Text] [Related]
17. Pericardial Effusion Following Hematopoietic Cell Transplantation in Children and Young Adults Is Associated with Increased Risk of Mortality.
Cox K; Punn R; Weiskopf E; Pinsky BA; Kharbanda S
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1165-1169. PubMed ID: 28390986
[TBL] [Abstract][Full Text] [Related]
18. Predictors and Outcome of Pericardial Effusion After Hematopoietic Stem Cell Transplantation in Children.
Versluys AB; Grotenhuis HB; Boelens MJJ; Mavinkurve-Groothuis AMC; Breur JMPJ
Pediatr Cardiol; 2018 Feb; 39(2):236-244. PubMed ID: 29058031
[TBL] [Abstract][Full Text] [Related]
19. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange.
Xu Y; Wei Y; Wang L; Lu N; Wu Y; Dou L; Liu D; Li M; Gao C
Ann Transplant; 2023 Jun; 28():e939890. PubMed ID: 37337423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
